This trial is looking at a new implant system that allows for communication between the body and a prosthetic limb using implanted electrodes. The study is to evaluate the feasibility of the system and will implant the system in two subjects.
3 Primary · 1 Secondary · Reporting Duration: 24 months
Experimental Treatment
2 Total Participants · 1 Treatment Group
Primary Treatment: e-OPRA Implant System for Transtibial Amputees · No Placebo Group · N/A
Age 22 - 65 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:| Nevada | 33.3% |
| Massachusetts | 33.3% |
| Michigan | 33.3% |
| 18 - 65 | 100.0% |
| Brigham and Women's Hospital | 33.3% |
| MIT Media Lab | 66.7% |
| Met criteria | 100.0% |
| 100.0% | |